Source: Northwestern Written By Kristin Samuelson December 21, 2022–All non-white racial and ethnic groups are underrepresented in OB-GYN clinical trials, reports a new Northwestern Medicine study. Since clinical trials and scientific publications inform clinical care, failing to report the race and ethnicity of study participants and conducting homogenous, non-representative research …
Read More »
Source: Parexel News Release BOSTON and Durham, N.C. May 20, 2021 — Parexel, a leading global clinical research organization (CRO), today announced the release of “Discussions on Diversity,” an in-depth research report and interactive microsite featuring patient, academic and physician voices highlighting the importance of diversity in clinical trials. The report, issued in …
Read More »
In 2015, the U.S. Food and Drug Administration launched a five-year action plan, aiming to improve diversity in clinical trials for newly approved drugs. According to HealthDay, Angela K. Green, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues analyzed Snapshots data to examine whether …
Read More »
Diversity MD
